Phase II Study of Low-Dose Interferon Alfa 2B (Schering Plough) Plus Thalidomide (Celgene) for Patients With Resected High-Risk Soft Tissue Sarcoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interferon alpha; Thalidomide
- Indications Sarcoma
- Focus Therapeutic Use
- 06 Jan 2014 Biomarkers information updated
- 01 Oct 2005 New trial record.